Jeffrey M Sobell

Guest Editor for the following articles:

Sep
2018
Vol. 37. No. 3

Targeted therapies for pediatric psoriasis

Gene Schwartz, MD | Amy S. Paller, MD

Children who are recalcitrant to topical therapy for their moderate to severe plaque psoriasis and/or highly visible lesions may be candidates for systemic therapy.

MORE
Sep
2013
Vol. 32. No. 3

Venous Eczema and Lipodermatosclerosis

Laurel M Morton, MD | Tania J Phillips, MD

Cutaneous changes are a common feature of chronic venous insufficiency and include venous eczema and lipodermatosclerosis. This review will address the presumed pathophysiology of these conditions, their clinical findings, and important management strategies.
Semin Cutan Med Surg 32:169-176 © 2013 Frontline Medical Communications

MORE
Sep
2018
Vol. 37. No. 3

Targeted therapies for psoriatic arthritis: an update for the dermatologist

Scott A. Elman, MD | Michael E. Weinblatt, MD | Joseph A. Merola, MD

With many new medications either on the market or currently being evaluated by the Food and Drug Administration, the purpose of this article is to review PsA for the dermatologist, to identify the current therapies that are available, and to help select which patients may benefit from these medications.

MORE